• No#766, Tongcheng Road
    Kunshan, Jiangsu Province,China

  • 86-21-2024 2659

  • Get A Quote

        Search:        

Building Block banner
5-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)-4-(difluoromethyl)pyridin-2-amine
Chemical Name: 5-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)-4-(difluoromethyl)pyridin-2-amine Catalog: 180510070
CAS Number: 1927857-56-4 Purity: 96.0% min
Package: 5g,10g,25g,100g,500g,1kg Price: POA
Lead Time: 2-4 weeks

Contact information

We sincerely hope that our Building Blocks can effectively streamline your R&D processes and significantly accelerate the pace of your research and development. Should you have more compounds that need to be custom made, please fell free to contact me via inquiry@pharmacore.cn

Recommended products

  • L-Canavanine sulfate

    190914792

    L-Canavanine sulfate

  • ethyl 2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetate

    190910755

    ethyl 2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetate

  • 1-(2-bromoethoxy)-2-[2-(2-bromoethoxy)ethoxy]ethane

    190927617

    1-(2-bromoethoxy)-2-[2-(2-bromoethoxy)ethoxy]ethane

  • 1-Phenylethane-1-thiol

    190918452

    1-Phenylethane-1-thiol

  • 4-[(2Z)-2-[(2E,4E)-5-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]penta-2,4-dienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

    190927669

    4-[(2Z)-2-[(2E,4E)-5-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]penta-2,4-dienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

  • 4-[(2Z)-2-[(E)-3-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

    190918508

    4-[(2Z)-2-[(E)-3-[1-(5-carboxypentyl)-3,3-dimethylindol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonate

Copyright @ PHARMACORE CO.,LIMITED. Our products are listed related to patents, for research purposes only, no commercial sales.

Back to the top